Literature DB >> 14718574

The human plasma proteome: a nonredundant list developed by combination of four separate sources.

N Leigh Anderson1, Malu Polanski, Rembert Pieper, Tina Gatlin, Radhakrishna S Tirumalai, Thomas P Conrads, Timothy D Veenstra, Joshua N Adkins, Joel G Pounds, Richard Fagan, Anna Lobley.   

Abstract

We have merged four different views of the human plasma proteome, based on different methodologies, into a single nonredundant list of 1175 distinct gene products. The methodologies used were 1) literature search for proteins reported to occur in plasma or serum; 2) multidimensional chromatography of proteins followed by two-dimensional electrophoresis and mass spectroscopy (MS) identification of resolved proteins; 3) tryptic digestion and multidimensional chromatography of peptides followed by MS identification; and 4) tryptic digestion and multidimensional chromatography of peptides from low-molecular-mass plasma components followed by MS identification. Of 1,175 nonredundant gene products, 195 were included in more than one of the four input datasets. Only 46 appeared in all four. Predictions of signal sequence and transmembrane domain occurrence, as well as Genome Ontology annotation assignments, allowed characterization of the nonredundant list and comparison of the data sources. The "nonproteomic" literature (468 input proteins) is strongly biased toward signal sequence-containing extracellular proteins, while the three proteomics methods showed a much higher representation of cellular proteins, including nuclear, cytoplasmic, and kinesin complex proteins. Cytokines and protein hormones were almost completely absent from the proteomics data (presumably due to low abundance), while categories like DNA-binding proteins were almost entirely absent from the literature data (perhaps unexpected and therefore not sought). Most major categories of proteins in the human proteome are represented in plasma, with the distribution at successively deeper layers shifting from mostly extracellular to a distribution more like the whole (primarily cellular) proteome. The resulting nonredundant list confirms the presence of a number of interesting candidate marker proteins in plasma and serum.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718574     DOI: 10.1074/mcp.M300127-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  205 in total

1.  Therapeutic effects of systemic administration of chaperone αB-crystallin associated with binding proinflammatory plasma proteins.

Authors:  Jonathan B Rothbard; Michael P Kurnellas; Sara Brownell; Chris M Adams; Leon Su; Robert C Axtell; Rong Chen; C Garrison Fathman; William H Robinson; Lawrence Steinman
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

Review 2.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Authors:  Nazila Kamaly; Zeyu Xiao; Pedro M Valencia; Aleksandar F Radovic-Moreno; Omid C Farokhzad
Journal:  Chem Soc Rev       Date:  2012-03-05       Impact factor: 54.564

Review 3.  Comparative human salivary and plasma proteomes.

Authors:  J A Loo; W Yan; P Ramachandran; D T Wong
Journal:  J Dent Res       Date:  2010-08-25       Impact factor: 6.116

Review 4.  Stability of IgG isotypes in serum.

Authors:  Ivan R Correia
Journal:  MAbs       Date:  2010-05-16       Impact factor: 5.857

Review 5.  The application of mass-spectrometry-based protein biomarker discovery to theragnostics.

Authors:  Jonathan M Street; James W Dear
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

6.  Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition.

Authors:  Hiroyuki Mori; Tyler C Prestwich; Michael A Reid; Kenneth A Longo; Isabelle Gerin; William P Cawthorn; Vedrana S Susulic; Venkatesh Krishnan; Andy Greenfield; Ormond A Macdougald
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

7.  Mixed stimuli-responsive magnetic and gold nanoparticle system for rapid purification, enrichment, and detection of biomarkers.

Authors:  Michael A Nash; Paul Yager; Allan S Hoffman; Patrick S Stayton
Journal:  Bioconjug Chem       Date:  2010-11-11       Impact factor: 4.774

Review 8.  Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.

Authors:  J Gustav Smith; Robert E Gerszten
Journal:  Circulation       Date:  2017-04-25       Impact factor: 29.690

9.  Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.

Authors:  Pavel Gromov; Irina Gromova; Jakob Bunkenborg; Teresa Cabezon; José M A Moreira; Vera Timmermans-Wielenga; Peter Roepstorff; Fritz Rank; Julio E Celis
Journal:  Mol Oncol       Date:  2009-11-23       Impact factor: 6.603

10.  Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach.

Authors:  Wei-Jun Qian; Matthew E Monroe; Tao Liu; Jon M Jacobs; Gordon A Anderson; Yufeng Shen; Ronald J Moore; David J Anderson; Rui Zhang; Steve E Calvano; Stephen F Lowry; Wenzhong Xiao; Lyle L Moldawer; Ronald W Davis; Ronald G Tompkins; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2005-03-07       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.